Myriad Genetics Signs Agreement with Nationally Renowned Sports Broadcaster Hannah Storm to Promote the Importance of Knowing Family Cancer History

Company Announcement - Myriad Genetics announced a partnership with Hannah Storm, a renowned sports broadcaster, to promote the Myriad Genetics Breast Cancer Risk Assessment Program [1] - Hannah Storm will serve as an ambassador for the MyRisk with RiskScore Hereditary Cancer Test, the industry-leading hereditary cancer and polygenic risk prediction test [2] - The partnership aims to raise awareness about the importance of family health history in understanding cancer risks [2] Product Details - MyRisk with RiskScore evaluates 48 genes associated with hereditary cancer risk and provides a five-year and lifetime breast cancer risk assessment [6] - The test identifies genetic changes linked to increased cancer risk for 11 different cancers and combines this with family history and clinical factors like breast density [6] Awareness Campaign - Hannah Storm will share content on her social media platforms about the importance of knowing family health history and having conversations about hereditary cancers [5] - The campaign will encourage women to discuss their family health history with healthcare providers and consider preventive steps [5] Industry Impact - Myriad Genetics is a leader in genetic testing and precision medicine, focusing on advancing health and well-being through genetic insights [7] - The company develops genetic tests that assess disease risk, guide treatment decisions, and improve patient care while lowering healthcare costs [7] Personal Story - Hannah Storm was diagnosed with stage zero Ductal Carcinoma in Situ (DCIS) in January 2024, detected through a routine mammogram and subsequent tests [4] - She emphasizes the importance of genetic testing for early detection and understanding potential hereditary risks for her daughters [3]